Selective, rapid and optically switchable regulation of protein function in live mammalian cells

Nature Chemistry

Volumn 7, Issue 7, 2015, Pages 554-561

  Tsai, Yu Hsuan ^a   Essig, Sebastian ^a   James, John R ^b   Lang, Kathrin ^a   Chin, Jason W ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN BINDING;

ANIMAL; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; PHOSPHORYLATION;

ANIMALS; CELLS, CULTURED; HUMANS; MODELS, MOLECULAR; PHOSPHORYLATION; PROTEIN BINDING; PROTEINS;

EID: 84932619425     PISSN: 17554330     EISSN: 17554349     Source Type: Journal    
DOI: 10.1038/nchem.2253     Document Type: Article

References (51)

1. Shogren-Knaak, M. A., Alaimo, P. J. & Shokat, K. M. Recent advantages in chemical approaches to the study of biological systems. Annu. Rev. Cell Dev. Biol. 17, 405-433 (2001).
2. Knight, Z. A. & Shokat, K. M. Chemical genetics: where genetics and pharmacology meet. Cell 128, 425-430 (2007).
3. Schreiber, S. L. Organic synthesis toward small-molecule probes and drugs. Proc. Natl Acad. Sci. USA 108, 6699-6702 (2011).
4. Belshaw, P. J., Schoepfer, J. G., Liu, K-Q., Morrison, K. L. & Schreiber, S. L. Rational design of orthogonal receptor-ligand combinations. Angew. Chem. Int. Ed. 34, 2129-2132 (1995).
5. Bishop, A. C. et al. A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature 407, 395-401 (2000).
6. Zheng, H., Al-Ayoubi, A. & Eblen, S. T. MAP Kinase Signaling Protocols Vol. 661 (Springer, 2010).
7. Erlanson, D. A., Wells, J. A. & Braisted, A. C. Tethering: fragment-based drug discovery. Annu. Rev. Biophys. Biomol. Struct. 33, 199-223 (2004).
8. Cravatt, B. F., Wright, A. T. & Kozarich, J. W. Activity-based protein profiling: from enzyme chemistry to proteomic chemistry. Annu. Rev. Biochem. 77, 383-414 (2008).
9. Takaoka, Y., Ojida, A. & Hamachi, I. Protein organic chemistry and applications for labeling and engineering in live-cell systems. Angew. Chem. Int. Ed. 52, 4088-4106 (2013).
10. Chen, Z., Jing, C., Gallagher, S. S., Sheetz, M. P. & Cornish, V. W. Secondgeneration covalent TMP-Tag for live cell imaging. J. Am. Chem. Soc. 134, 13692-13699 (2012).
11. Liu, Q. et al. Developing irreversible inhibitors of the protein kinase cysteinome. Chem. Biol. 20, 146-159 (2013).
12. Blair, J. A. et al. Structure-guided development of affinity probes for tyrosine kinases using chemical genetics. Nature Chem. Biol. 3, 229-238 (2007).
13. Volgraf, M. et al. Allosteric control of an ionotropic glutamate receptor with an optical switch. Nature Chem. Biol. 2, 47-52 (2006).
14. Fehrentz, T., Schönberger, M. & Trauner, D. Optochemical genetics. Angew. Chem. Int. Ed. 50, 12156-12182 (2011).
15. Szymański, W., Beierle, J. M., Kistemaker, H. A. V., Velema, W. A. & Feringa, B. L. Reversible photocontrol of biological systems by the incorporation of molecular photoswitches. Chem. Rev. 113, 6114-6178 (2013).
16. Sletten, E. M. & Bertozzi, C. R. Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. Angew. Chem. Int. Ed. 48, 6974-6998 (2009).
17. Lang, K. & Chin, J.W. Bioorthogonal reactions for labeling proteins. ACS Chem. Biol. 9, 16-20 (2014).
18. Lang, K. & Chin, J. W. Cellular incorporation of unnatural amino acids and bioorthogonal labeling of proteins. Chem. Rev. 114, 4764-4806 (2014).
19. Lang, K. et al. Genetically encoded norbornene directs site-specific cellular protein labelling via a rapid bioorthogonal reaction. Nature Chem. 4, 298-304 (2012).
20. Plass, T. et al. Amino acids for Diels-Alder reactions in living cells. Angew. Chem. Int. Ed. 51, 4166-4170 (2012).
21. Kaya, E. et al. A genetically encoded norbornene amino acid for the mild and selective modification of proteins in a copper free click reaction. Angew. Chem. Int. Ed. 51, 4466-4469 (2012).
22. Seitchik, J. L. et al. Genetically encoded tetrazine amino acid directs rapid sitespecific in vivo bioorthogonal ligation with trans-cyclooctenes. J. Am. Chem. Soc. 134, 2898-2901 (2012).
23. Lang, K. et al. Genetic encoding of bicyclononynes and trans-cyclooctenes for site-specific protein labeling in vitro and in live mammalian cells via rapid fluorogenic Diels-Alder reactions. J. Am. Chem. Soc. 134, 10317-10320 (2012).
24. Elliott, T. S. et al. Proteome labeling and protein identification in specific tissues and at specific developmental stages in an animal. Nature Biotechnol. 32, 465-472 (2014).
25. Bianco, A., Townsley, F. M., Greiss, S., Lang, K. & Chin, J. W. Expanding the genetic code of Drosophila melanogaster. Nature Chem. Biol. 8, 748-750 (2012).
26. Krishnamurthy, V. M. et al. Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding. Chem. Rev. 108, 946-1051 (2008).
27. Vauquelin, G. Simplified models for heterobivalent ligand binding: when are they applicable and which are the factors that affect their target residence time. Naunyn-Schmiedeberg's Arch. Pharmacol. 386, 949-962 (2013).
28. Gargano, J. M., Ngo, T., Kim, J. Y., Acheson, D. W. K. & Lees, W. J. Multivalent inhibition of AB5 toxins. J. Am. Chem. Soc. 123, 12909-12910 (2001).
29. Krishnamurthy, V. M., Semetey, V., Bracher, P. J., Shen, N. & Whitesides, G. M. Dependence of effective molarity on linker length for an intramolecular protein-ligand system. J. Am. Chem. Soc. 129, 1312-1320 (2007).
30. Hilger, R. A., Scheulen, M. E. & Strumberg, D. The Ras-Raf-MEK-ERK pathway in the treatment of cancer. Oncol. Res. Treat. 25, 511-518 (2002).
31. Sebolt-Leopold, J. S. & Herrera, R. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nature Rev. Cancer 4, 937-947 (2004).
32. Solit, D. B. et al. BRAF mutation predicts sensitivity to MEK inhibition. Nature 439, 358-362 (2006).
33. Brott, B. K. et al. Mek2 is a kinase related to Mek1 and Ts differentially expressed in murine tissues. Cell Growth Differ. 4, 921-929 (1993).
34. Giroux, S. et al. Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr. Biol. 9, 369-376 (1999).
35. Ussar, S. & Voss, T. MEK1 and MEK2, different regulators of the G1/S transition. J. Biol. Chem. 279, 43861-43869 (2004).
36. Zhao, Y. & Adjei, A. A. The clinical development of MEK inhibitors. Nature Rev. Clin. Oncol. 11, 385-400 (2014).
37. Tecle, H. et al. Beyond the MEK-pocket: can current MEK kinase inhibitors be utilized to synthesize novel type III NCKIs? Does the MEK-pocket exist in kinases other than MEK? Bioorg. Med. Chem. Lett. 19, 226-229 (2009).
38. Rice, K. D. et al. Novel carboxamide-based allosteric MEK inhibitors: discovery and optimization efforts toward XL518 (GDC-0973). ACS Med. Chem. Lett. 3, 416-421 (2012).
39. Yao, J. Z. et al. Fluorophore targeting to cellular proteins via enzyme-mediated azide ligation and strain-promoted cycloaddition. J. Am. Chem. Soc. 134, 3720-3728 (2012).
40. Barrett, S. D., Biwersi, C., Kaufman, M., Tecle, H. & Warmus, J. S. Oxygenated esters of 4-iodo phenylamino benzhydroxamic acid. International patent WO 02/06213 (2002).
41. Hamon, F., Djedaini-Pilard, F., Barbot, F. & Len, C. Azobenzenes-synthesis and carbohydrate applications. Tetrahedron 65, 10105-10123 (2009).
42. Renner, C. & Moroder, L. Azobenzene as conformational switch in model peptides. Chem Bio Chem 7, 868-878 (2006).
43. Beharry, A. A., Wong, L., Tropepe, V. & Woolley, G. A. Fluorescence imaging of azobenzene photoswitching in vivo. Angew. Chem. Int. Ed. 50, 1325-1327 (2011).
44. Tang, P. C. et al. Pyrrole substituted 2-indolinone protein kinase inhibitors. US patent 6,573,293 (2003).
45. Gajiwala, K. S. et al. KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients. Proc. Natl Acad. Sci. USA 106, 1542-1547 (2009).
46. Palacios, E. H. & Weiss, A. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 23, 7990-8000 (2004).
47. James, J. R. & Vale, R. D. Biophysical mechanism of T-cell receptor triggering in a reconstituted system. Nature 487, 64-69 (2012).
48. Au-Yeung, B. B. et al. The structure, regulation, and function of ZAP-70. Immunol. Rev. 228, 41-57 (2009).
49. Schmied, W. H., Elsässer, S. J., Uttamapinant, C. & Chin, J.W. Efficient multisite unnatural amino acid incorporation in mammalian cells via optimized pyrrolysyl tRNA synthetase/tRNA expression and engineered eRF1. J. Am. Chem. Soc. 136, 15577-15583 (2014).
50. Sander, J. D. & Joung, J. K. CRISPR-Cas systems for editing, regulating and targeting genomes. Nature Biotechnol. 32, 347-355 (2014).
51. Mansour, S. et al. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265, 966-970 (1994).